Search

Your search keyword '"O-glycosylation, Sialuria OMIM 269921"' showing total 2 results
Start Over Descriptor "O-glycosylation, Sialuria OMIM 269921"
2 results on '"O-glycosylation, Sialuria OMIM 269921"'

1. Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria

Author

Wopereis, Suzan, Abd Hamid, Umi M., Critchley, Alison, Royle, Louise, Dwek, Raymond A., Morava, Éva, Leroy, Jules G., Wilcken, Bridget, Lagerwerf, Aart J., Huijben, Karin M.L.C., Lefeber, Dirk J., Rudd, Pauline M., and Wevers, Ron A.

Subjects
*ELECTROPHORESIS, *ORGANIC chemistry, *SERUM, *BLOOD plasma
Abstract

Abstract: Sialuria is an inborn error of metabolism characterized by coarse face, hepatomegaly and recurrent respiratory tract infections. The genetic defect in this disorder results in a loss of feedback control of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine-kinase by CMP-N-acetylneuraminic acid (CMP-NeuAc) resulting in a substantial overproduction of cytoplasmic free sialic acid. This study addresses fibroblast CMP-NeuAc levels and N- and O-glycan sialylation of serum proteins from Sialuria patients. CMP-NeuAc levels were measured with HPLC in fibroblasts. Isoelectric focusing (IEF) of serum transferrin and of apolipoprotein C-III (apoC-III) was performed on serum of three Sialuria patients. Isoforms of these proteins can be used as specific markers for the biosynthesis of N- and core 1 O-glycans. Furthermore, total N- and O-linked glycans from serum proteins were analyzed by HPLC. HPLC showed a clear overproduction of CMP-NeuAc in fibroblasts of a Sialuria patient. Minor changes were found for serum N-glycans and hypersialylation was found for core 1 O-glycans on serum apoC-III and on total serum O-glycans in Sialuria patients. HPLC showed an increased ratio of disialylated over monosialylated core 1 O-glycans. The hypersialylation of core 1 O-glycans is due to the increase of NeuAcα2,6-containing structures (mainly NeuAcα2-3Galβ1-3[NeuAcα2-6]GalNAc). This may relate to K M differences between GalNAc-α2,6-sialyltransferase and α2,3-sialyltransferases. This is the first study demonstrating that the genetic defect in Sialuria results in a CMP-NeuAc overproduction. Subsequently, increased amounts of α2,6-linked NeuAc were found on serum core 1 O-glycans from Sialuria patients. N-glycosylation of serum proteins seems largely unaffected. Sialuria is the first metabolic disorder presenting with hypersialylated O-glycans. [Copyright &y& Elsevier]

Published
2006
Full Text
View/download PDF

2. Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria

Author

Suzan Wopereis, Louise Royle, Bridget Wilcken, Umi Marshida Abd Hamid, Raymond A. Dwek, Pauline M. Rudd, Eva Morava, Jules G. Leroy, Karin Huijben, Ron A. Wevers, Alison J. Critchley, Dirk Lefeber, and Aart J. Lagerwerf

Subjects
Sialuria, Glycosylation, Energy and redox metabolism [NCMLS 4], Hypersialylation, Core I O-glycans, N-glycosylation, Neuroinformatics [DCN 3], Genomic disorders and inherited multi-system disorders [IGMD 3], chemistry.chemical_compound, Polysaccharides, medicine, Perception and Action [DCN 1], Humans, Protein Isoforms, Apolipoproteins C, Molecular Biology, Chromatography, High Pressure Liquid, Glycoproteins, chemistry.chemical_classification, Apolipoprotein C-III, Nucleotides, Sialic Acid Storage Disease, Transferrin, O-glycosylation, Sialuria OMIM 269921, Glycostation disorders [IGMD 4], medicine.disease, Molecular biology, Blood proteins, N-Acetylneuraminic Acid, Neuromuscular development and genetic disorders [UMCN 3.1], Sialic acid, carbohydrates (lipids), Mitochondrial medicine [IGMD 8], chemistry, Biochemistry, Genetic defects of metabolism [UMCN 5.1], Inborn error of metabolism, Molecular Medicine, Isoelectric Focusing, Glycoprotein, N-Acetylneuraminic acid
Abstract

Contains fulltext : 50045.pdf (Publisher’s version ) (Closed access) Sialuria is an inborn error of metabolism characterized by coarse face, hepatomegaly and recurrent respiratory tract infections. The genetic defect in this disorder results in a loss of feedback control of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine-kinase by CMP-N-acetylneuraminic acid (CMP-NeuAc) resulting in a substantial overproduction of cytoplasmic free sialic acid. This study addresses fibroblast CMP-NeuAc levels and N- and O-glycan sialylation of serum proteins from Sialuria patients. CMP-NeuAc levels were measured with HPLC in fibroblasts. Isoelectric focusing (IEF) of serum transferrin and of apolipoprotein C-III (apoC-III) was performed on serum of three Sialuria patients. Isoforms of these proteins can be used as specific markers for the biosynthesis of N- and core 1 O-glycans. Furthermore, total N- and O-linked glycans from serum proteins were analyzed by HPLC. HPLC showed a clear overproduction of CMP-NeuAc in fibroblasts of a Sialuria patient. Minor changes were found for serum N-glycans and hypersialylation was found for core 1 O-glycans on serum apoC-III and on total serum O-glycans in Sialuria patients. HPLC showed an increased ratio of disialylated over monosialylated core 1 O-glycans. The hypersialylation of core 1 O-glycans is due to the increase of NeuAcalpha2,6-containing structures (mainly NeuAcalpha2-3Galbeta1-3[NeuAcalpha2-6]GalNAc). This may relate to KM differences between GalNAc-alpha2,6-sialyltransferase and alpha2,3-sialyltransferases. This is the first study demonstrating that the genetic defect in Sialuria results in a CMP-NeuAc overproduction. Subsequently, increased amounts of alpha2,6-linked NeuAc were found on serum core 1 O-glycans from Sialuria patients. N-glycosylation of serum proteins seems largely unaffected. Sialuria is the first metabolic disorder presenting with hypersialylated O-glycans.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results